ORILISSA
Identification of Orilissa
| No description |
Google image searchProduct monograph
Active ingredient
elagolix (elagolix sodium), 150 MG
DIN: 02481332
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 30-OCT-2018
ATC:
- G03 — SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (ATC, ATC/DDD, )
- G03X — OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (ATC, ATC/DDD)
- G03XA — Antigonadotropins and similar agents (ATC, ATC/DDD)
